Literature DB >> 22426038

Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue.

Dong-Wang Yan1, Jun-Wei Fan, Zhen-Hai Yu, Ming-Xue Li, Yu-Gang Wen, Da-Wei Li, Chong-Zhi Zhou, Xiao-Liang Wang, Quan Wang, Hua-Mei Tang, Zhi-Hai Peng.   

Abstract

PURPOSE: Downregulation of metallothionein (MT) genes has been reported in several tumors with discrepant results. This study is to investigate molecular mechanism of MT gene regulation in colon cancer which is characterized by tumor suppressor gene alterations. EXPERIMENTAL
DESIGN: Integral analysis of microarray data with loss of heterozygosity (LOH) information was employed. Quantitative real-time PCR and immunohistochemistry were used to validate MT isoform expression in colon cancer tissues and cell lines. The effects of MT1F expression on RKO cell survival and tumorigenesis was analyzed. Bisulphite sequencing PCR (BSP) and methylation-specific PCR were employed to detect the methylation status of the MT1F gene in colon cancer tissues and cell lines. DNA sequencing was used to examine the LOH at the MT1F locus.
RESULTS: MT1F, MT1G, MT1X, and MT2A gene expression was significantly downregulated in colon cancer tissue (p<0.05). Exogenous MT1F expression increased RKO cell apoptosis and inhibited RKO cell migration, invasion and adhesion as well as in vivo tumorigenicity. Downregulation of MT1F gene in majority of human colon tumor tissues is mainly through mechanism by loss of heterozygosity (p=0.001) while CpG island methylation of MT1F gene promoter region was only observed in poorly differentiated, MSI-positive RKO and LoVo colon cancer cell lines.
CONCLUSIONS: MT1F is a putative tumor suppressor gene in colon carcinogenesis that is downregulated mainly by LOH in colon cancer tissue. Further studies are required to elucidate a possible role for MT1F downregulation in colon cancer initiation and/or progression.
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22426038     DOI: 10.1016/j.bbadis.2012.02.021

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  23 in total

1.  Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.

Authors:  Zhi Li; Shengtao Lin; Tao Jiang; Jingtao Wang; Huijun Lu; Huamei Tang; Mujian Teng; Junwei Fan
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  The pleiotropic effects of fisetin and hesperetin on human acute promyelocytic leukemia cells are mediated through apoptosis, cell cycle arrest, and alterations in signaling networks.

Authors:  Aysun Adan; Yusuf Baran
Journal:  Tumour Biol       Date:  2015-06-17

3.  Highly synergistic effect of sequential treatment with epigenetic and anticancer drugs to overcome drug resistance in breast cancer cells is mediated via activation of p21 gene expression leading to G2/M cycle arrest.

Authors:  Sivakumar Vijayaraghavalu; Josephine Kamtai Dermawan; Venugopalan Cheriyath; Vinod Labhasetwar
Journal:  Mol Pharm       Date:  2012-12-24       Impact factor: 4.939

4.  Cullin 4B is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.

Authors:  Tao Jiang; Hua-mei Tang; Ze-hua Wu; Jian Chen; Su Lu; Chong-zhi Zhou; Dong-wang Yan; Zhi-hai Peng
Journal:  Med Oncol       Date:  2013-05-07       Impact factor: 3.064

5.  Overexpression of RBBP6, alone or combined with mutant TP53, is predictive of poor prognosis in colon cancer.

Authors:  Jian Chen; Huamei Tang; Zehua Wu; Chongzhi Zhou; Tao Jiang; Yingming Xue; Guoyu Huang; Dongwang Yan; Zhihai Peng
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

6.  Role of metallothioneins in benign and malignant thyroid lesions.

Authors:  Bartosz Pula; Pawel Domoslawski; Marzena Podhorska-Okolow; Piotr Dziegiel
Journal:  Thyroid Res       Date:  2012-12-28

7.  Comparative transcriptome profiling of an SV40-transformed human fibroblast (MRC5CVI) and its untransformed counterpart (MRC-5) in response to UVB irradiation.

Authors:  Cheng-Wei Chang; Chaang-Ray Chen; Chao-Ying Huang; Wun-Yi Shu; Chi-Shiun Chiang; Ji-Hong Hong; Ian C Hsu
Journal:  PLoS One       Date:  2013-09-03       Impact factor: 3.240

8.  The role of metallothionein in oxidative stress.

Authors:  Branislav Ruttkay-Nedecky; Lukas Nejdl; Jaromir Gumulec; Ondrej Zitka; Michal Masarik; Tomas Eckschlager; Marie Stiborova; Vojtech Adam; Rene Kizek
Journal:  Int J Mol Sci       Date:  2013-03-15       Impact factor: 5.923

9.  SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression.

Authors:  R Tiwari; S K Pandey; S Goel; V Bhatia; S Shukla; X Jing; S M Dhanasekaran; B Ateeq
Journal:  Oncogenesis       Date:  2015-08-10       Impact factor: 7.485

10.  Metallothionein 2A inhibits NF-κB pathway activation and predicts clinical outcome segregated with TNM stage in gastric cancer patients following radical resection.

Authors:  Yuanming Pan; Jiaqiang Huang; Rui Xing; Xin Yin; Jiantao Cui; Wenmei Li; Jun Yu; Youyong Lu
Journal:  J Transl Med       Date:  2013-07-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.